These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 190536)

  • 21. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
    Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
    Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenic syndrome studied with single fiber electromyography.
    Schwartz MS; Stålberg E
    Arch Neurol; 1975 Dec; 32(12):815-7. PubMed ID: 173269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myasthenia, a model of a disease caused by auto-antibodies].
    Goulon M; Gajdos P; Goulon-Goëau C
    Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the impaired neuromuscular transmission in myasthenia gravis].
    Kruckenberg P; Pontzen W; Sandweg R; Bauer H
    Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
    [No Abstract]   [Full Text] [Related]  

  • 27. [The evidence of antibodies against motor endplates of the skeletal muscle in myasthenia gravis with the double immune-fluorescence technique (author's transl)].
    Storch W; Trautmann B
    Acta Histochem; 1981; 69(1):18-22. PubMed ID: 6795885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient myasthenia of the newborn. Clinical and electromyographic studies.
    Wise GA; McQuillen MP
    Trans Am Neurol Assoc; 1969; 94():100-5. PubMed ID: 4313956
    [No Abstract]   [Full Text] [Related]  

  • 30. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
    Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
    J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evoked responses in normal and diseased muscle with particular reference to twitch potentiation.
    Krarup C
    Acta Neurol Scand; 1983 Nov; 68(5):269-315. PubMed ID: 6320576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human disease transferred to mice: myasthenia gravis.
    Dawson DM
    N Engl J Med; 1977 Jan; 296(3):168-9. PubMed ID: 831078
    [No Abstract]   [Full Text] [Related]  

  • 33. Myasthenia gravis--validation of a hypothesis.
    Simpson JA
    Scott Med J; 1977 Jul; 22(3):201-10. PubMed ID: 196330
    [No Abstract]   [Full Text] [Related]  

  • 34. A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient.
    Taphoorn MJ; Van Duijn H; Wolters EC
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):880-2. PubMed ID: 2841430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Single fiber electromyography in myasthenia gravis].
    Huang SR
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Dec; 19(6):345-8. PubMed ID: 3034526
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
    Oda K; Shibasaki H
    Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy.
    Ahlsten G; Lefvert AK; Osterman PO; Stålberg E; Säfwenberg J
    J Child Neurol; 1992 Jul; 7(3):264-9. PubMed ID: 1634748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
    Simpson JA
    Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
    Gomez CM; Richman DP
    J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.